StockOrNot
Open the deck

Colgate-Palmolive (CL)

Consumer Staples · $77.9B market cap · SEC CIK 0000021665

$98.09 ▲+0.15% on the day close of Nov 10, 2026
48 Mixed
ahead of 48% of the S&P 500 · #19 of 36 in Consumer Staples

Next reports on Jan 28, 2027, after the close, with analysts expecting $1.01 in earnings per share.

52-week range $75.96 to $101.18. 3% below its 52-week high and 29% above its low.

The case for CL

The case against

What the score is made of

Each factor is half a curve over reported figures and half a rank among the other Consumer Staples companies (momentum is judged against fixed thresholds only), and the five are blended by weight. The score is where that blend places it in the S&P 500. It describes the last filing and the current price. It is not a forecast.

Valuewhat you pay for the earnings and cash, against the growth you get31
Growthhow fast revenue and earnings are moving, this year and over five33
Profitabilityhow much of the revenue becomes profit, and how much of that is cash67
Momentumhow the price has behaved lately73
Stabilityhow violently it moves, what it owes and what it pays you86

The financials

Revenue growth

Is the business growing? Slowly

Last 12 months+5.9%
Over 5 years+4.3% a year
FY2025 revenue$20.4B (+1%)

Free cash flow

Is it generating real cash? Yes, plenty

FY2025 free cash flow$3.6B
Of revenue18%
Of profit170%

Profit margins

Is profitability improving? No, slipping

Gross margin61%
Operating margin15%
Net margin, FY24 → FY25 → now14.4% → 10.5% → 9.7%

Debt vs. cash

Is the balance sheet healthy? Yes, the debt is manageable

Cash$1.3B
Long-term debt$6.9B
Net debt$5.6B
Years to repay1.6 yrs

Valuation

Is the stock price reasonable? No, expensive

P/E38.0×
Fair P/E for its growth15×
P/FCF21.4×
Forward P/E23.5×
EV / EBITDA22.1×

At 38.0× earnings it trades well above the 15× that 2% a year of growth plus a 2.5% dividend would justify. At 21.4× free cash flow it trades above that same mark.

The financials, five years deep

Pulled from Colgate-Palmolive's XBRL filings on SEC EDGAR. Italic rows are worked out from the others.

FY2025FY2024FY2023FY2022FY2021
Revenue growth
Revenue$20.4B$20.1B$19.5B$18.0B$17.4B
Change on the year+1%+3%+8%+3%—
Free cash flow
Free cash flow$3.6B$3.5B$3.0B$1.9B$2.8B
Of revenue18%18%16%10%16%
Profit margins
Gross margin60.1%60.5%58.2%57.0%59.6%
Operating margin16.2%21.2%20.5%16.1%19.1%
Net margin10.5%14.4%11.8%9.9%12.4%
Debt vs. cash
Cash$1.3B$1.1B$966M$775M$832M
Long-term debt$6.9B$7.3B$8.2B$8.7B$7.2B
Net cash (debt)−$5.6B−$6.2B−$7.3B−$8.0B−$6.4B

What Colgate-Palmolive says it does

Development of the Business Colgate-Palmolive Company (together with its subsidiaries, “we,” “us,” “our,” the “Company” or “Colgate-Palmolive”) is a caring, innovative growth company united behind our purpose to reimagine a healthier future for all people, their pets and our planet. To achieve our business and financial objectives and deliver peer-leading performance and total shareholder return, we are focused on driving organic sales growth; delivering consistent, compounded earnings per share growth; achieving operational efficiencies; and driving growth in free cash flow along with the efficient use of our balance sheet. We do this by leveraging the global reach and penetration of our brands; building the incremental benefit of superior, science-based innovation supported by an agile and resilient supply chain; harnessing the power of best-in-class omni-channel demand generation; leading in capabilities such as data, analytics and…

Risk factors CL lists in its 10-K

Filings

Open CL in the deck

Other Consumer Staples companies

WMTWalmartCOSTCostcoKOCoca-ColaPGProcter & GamblePMPhilip Morris InternationalPEPPepsiCoMOAltriaMNSTMonster BeverageMDLZMondelez InternationalTGTTarget CorporationKMBKimberly-ClarkKDPKeurig Dr Pepper